Cingulate and Indegene sign agreement for lead ADHD candidate CTx-1301 EP News Bureau Mar 14, 2023 The agreement spans cross-functional services through an omnichannel marketing approach designed to manage pre-commercial support…
Glenmark Pharma gets USFDA approval for Amphetamine Sulfate Tablets EP News Bureau Jan 28, 2021 The tablets are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, a sleeping disorder
